Abstract
Mastitis remains the most costly infectious disease, and the most frequent cause of antibacterial use on commercial dairy farms. As such, research should continue on the development and validation of new management tools that will help reduce the health and economic impact of this disease, while at the same time promoting the judicious and strategic use of antimicrobials on dairy farms. The adoption of on-farm culture systems may allow producers to make more strategic mastitis treatment decisions, potentially reducing antimicrobial use while maintaining the future production potential of the cow. The objective of this study was to describe the effect of using an on-farm culture system to guide strategic treatment of clinical mastitis cases on intramammary antibiotic use and bacteriological cure rates in affected quarters.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Association of Bovine Practitioners Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
